Health care debates often focus on budget numbers or policy goals. Seldom do we hear how policy changes will affect actual patients. Take what the Food and Drug Administration (FDA) is doing with the late-stage cancer drug Avastin.
The egg that is the president’s health care reform legislation is starting to crack.
Iranian Exiles Have Suffered as We Have Ignored Tehran’s Expanding Influence in Iraq | Leo McCloskey